High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

Teresa M. Cardesa‐Salzmann; Lluı́s Colomo; Gonzalo Gutiérrez; Wing C. Chan; Dennis D. Weisenburger

doi:10.3324/haematol.2010.037408

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

Teresa M. Cardesa‐Salzmann, Lluı́s Colomo, Gonzalo Gutiérrez, Wing C. Chan, Dennis D. Weisenburger, Fina Climent, Eva González‐Barca, Santiago Mercadal, Leonor Arenillas, Sérgio Serrano, R. Tubbs, Jan Delabie, Randy D. Gascoyne, Joseph M. Connors, José Luís Mate...

Ferrata Storti Foundation (2011) • Volume 96, Issue 7, Pages 996-1001

PDF Available

Abstract

These findings highlight the impact of angiogenesis in the outcome of patients with diffuse large B-cell lymphoma and the interest of evaluating antiangiogenic drugs in clinical trials.

Quick Actions

Read Full Paper

Publication Info

DOI

10.3324/haematol.2010.037408

Language

English

Topic

Lymphoma Diagnosis and Treatment

Keywords

International Prognostic Index, Medicine, Rituximab, Lymphoma, Internal medicine, Diffuse large B-cell lymphoma, Microvessel, Oncology, Pathology, Cohort, Proportional hazards model, Angiogenesis

Published

May 5, 2011

Citations

127 citations

FWCI

5.23

External Resources

DOI Link OpenAlex

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

Abstract

Quick Actions

Publication Info

External Resources

Suggested Papers

associated_data_Investigating the Effectiveness of clDice Loss for Road Crack Segmentation

The Annals of Internal Medicine

Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials

Suggested Papers

Suggested Papers

associated_data_Investigating the Effectiveness of clDice Loss for Road Crack Segmentation

The Annals of Internal Medicine

Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials